PWP
RVNC
Perfromance Wealth Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-16,500
| Closed | -$81.2K | – | 184 |
|
|
2024
Q1 | $81.2K | Buy |
+16,500
| New | +$81.2K | ﹤0.01% | 164 |
|
|
2023
Q4 | – | Sell |
-18,500
| Closed | -$212K | – | 179 |
|
|
2023
Q3 | $212K | Hold |
18,500
| – | – | 0.01% | 158 |
|
|
2023
Q2 | $457K | Buy |
18,500
+3,000
| +19% | +$74.2K | 0.02% | 123 |
|
|
2023
Q1 | $499K | Buy |
15,500
+2,500
| +19% | +$80.5K | 0.03% | 112 |
|
|
2022
Q4 | $240K | Hold |
13,000
| – | – | 0.01% | 145 |
|
|
2022
Q3 | $351K | Hold |
13,000
| – | – | 0.02% | 116 |
|
|
2022
Q2 | $180K | Hold |
13,000
| – | – | 0.01% | 163 |
|
|
2022
Q1 | $254K | Hold |
13,000
| – | – | 0.01% | 149 |
|
|
2021
Q4 | $212K | Buy |
+13,000
| New | +$212K | 0.01% | 172 |
|